PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.24%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
4.05%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
-3.20%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-0.98%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
7.98%
R&D change of 7.98% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.56%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
1.46%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
102.09%
D&A growth above 1.5x CRWV's 26.15%. Michael Burry would check for excessive investment.
1.40%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
8.23%
Similar EBITDA margin growth to CRWV's 7.69%. Walter Schloss would investigate industry trends.
-6.14%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-3.98%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-8.71%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-6.61%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-4.47%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-6.65%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-6.59%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-4.45%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-8.00%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-8.33%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
0.11%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
-0.13%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.